Trial Profile
Efficacy and safety of fixed-dose combination of ledipasvir/sofosbuvir in patients with hepatitis C virus genotype-1b Infection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Jan 2017
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 06 Jan 2017 New trial record